Prime Medicine
0 followers
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and r... Read more
Org chart
Keith Gottesdiener
President & CEO
Keith Gottesdiener
Collapse
Andrew Anzalone
Co-Founder & Head of Prime Editing Platform
Ann Lee
CTO
Niamh Alix
CHRO
Carman Alenson
CAO & SVP, Finance
Karen Brown
SVP, Intellectual Property & Legal Affairs
Mohammed Asmal
SVP & Head of Clinical
Meredith Goldwasser
SVP & Head of Strategy & Corporate Operations
Fubao Wang
SVP & Head of Regulatory Affairs
Chris Bell
Vice President
Yune Kunes
Vp, Head Of Analytical Development, Formulation And Early Stage QC
John R. Hadcock, Ph.D.
Vice President, Nonclinical Development And Pharmacology
Jean Marzilli
Head of Talent Acquisition
Yi Pu
Group Head
Barrett Nehilla
Sr Director, Cell Therapy Process Development & Head Of CMC Portfolio Management
Robert Greene
Senior Director, Head Of External Manufacturing
Ze (Cindy) Liu
Associate Director, Analytical Development-molecular Group Lead
Anita R.
Executive Assistant to CSO
Alexandria Petrusich
Vice President Clinical Science
Aaron Chang
VP Computational Sciences
Jennifer Gori
Vice President And Head Of Hematology & Immunology
